Company: HURA
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001193125-25-137135
Chunk: 7

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-06-06
Form: 8-K
Item: Item 9.01
Chunk 7
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No                                                                                   
         4.1      Form of Warrant.                                                             
        10.1      Form of Securities Purchase Agreement.                                       
        99.1      Press Release, dated June 3, 2025                                            
         104      Cover Page Interactive Data File (embedded within the inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                   TUHURA BIOSCIENCES, INC.        
  Date: June 6, 2025      By:      /s/ Dan Dearborn                
                                   Name: Dan Dearborn              
                                   Title: Chief Financial Officer